SAM
PROF

Silvercrest Asset Management’s Profound Medical PROF Stock Holding History

Silvercrest Asset Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,001
Closed -$119K – 861
2024
Q3 		$119K Hold
15,001
– – ﹤0.01% 792
2024
Q2 		$126K Hold
15,001
– – ﹤0.01% 876
2024
Q1 		$128K Sell
15,001
-52,000
-78% -$434K ﹤0.01% 862
2023
Q4 		$569K Buy
+67,001
New +$636K ﹤0.01% 650

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Silvercrest Asset Management's PROF Position: Q4 2024 in Review

Silvercrest Asset Management sold out of Profound Medical (PROF) in Q4 2024, closing a stake of 15,001 shares — an estimated $119K sold.

Silvercrest Asset Management first reported a position in PROF in Q4 2023 and held it in 4 quarters. The position peaked at $569K in Q4 2023. 52 funds tracked by Wall St. Rank hold PROF as of Q4 2024.

  • Silvercrest Asset Management reported no remaining Profound Medical position as of Q4 2024 after selling out during the quarter.
  • Silvercrest Asset Management sold 15,001 Profound Medical shares in Q4 2024, an estimated $119K.
  • Silvercrest Asset Management first reported a position in Profound Medical in Q4 2023 and held it in 4 quarters.
  • Silvercrest Asset Management's Profound Medical position peaked at $569K in Q4 2023.
  • 52 funds tracked by Wall St. Rank held Profound Medical as of Q4 2024.

Based on Silvercrest Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.